Sort
10,766 grants matching “checkpoint inhibitor”
Adoptive T Cell Therapy for Pancreatic Cancer
$613,867Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
$613,843Donald Ym Leung · National Jewish Health · U01 · FY2023 · AR
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$613,358Jin Wang · Baylor College Of Medicine · R01 · FY2024 · CA
Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors
$613,316Terry A Badger · University Of Arizona · R01 · FY2024 · CA
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$613,059Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Radiation and dendritic cells to hepatomas to improve immunotherapy response
$612,951Sean S Park · Mayo Clinic Rochester · R01 · FY2024 · CA
Inhibiting Multi-Functional ALDOA for Cancer Therapy
$612,848Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · CA
Mechanism of spontaneous and DSB-induced repair
$612,421Rodney J. Rothstein · Columbia University Health Sciences · R37 · FY2012 · GM
Cancer Immunotherapy Clinical Trials
$612,359Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Dissecting a novel tumor-promoting axis in cholangiocarcinoma
$612,322Daniela Sia · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Dissecting a novel tumor-promoting axis in cholangiocarcinoma
$612,322Daniela Sia · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
$612,272David G Denardo · Washington University · U01 · FY2024 · CA
Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut
$612,247Michael Lawrence Dougan · Massachusetts General Hospital · R01 · FY2022 · AI
Evaluation of Novel Radiation Modifiers
$612,188Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
$612,099Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA
Radiation and dendritic cells to hepatomas to improve immunotherapy response
$612,054Sean S Park · Mayo Clinic Rochester · R01 · FY2023 · CA
Mechanism of lysyl oxidase propeptide in oral squamous cell carcinoma microenvironments
$612,048Philip C Trackman · Ada Forsyth Institute, Inc. · R56 · FY2024 · DE
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
$611,800Binghui Shen · Beckman Research Institute/City Of Hope · U01 · FY2025 · CA
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
$611,615William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
$611,442Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Precision targeting of T cell cytotoxicity with PET
$611,272Michael John Evans · University Of California, San Francisco · R01 · FY2024 · CA
Mechanism of spontaneous and DSB-induced repair
$611,183Rodney J. Rothstein · Columbia University Health Sciences · R37 · FY2011 · GM
Microtubule Regulation
$611,119Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R01 · FY2009 · GM
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
$610,938Donald Ym Leung · National Jewish Health · U01 · FY2022 · AR
Biomarkers for acute interstitial nephritis in humans
$610,901Dennis G. Moledina · Yale University · R01 · FY2022 · DK